| Tag | Content |
|---|
EnhancerAtlas ID | HS118-10954 |
Organism | Homo sapiens |
Tissue/cell | Liver |
Coordinate | chr2:225774240-225775660 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Atoh1 | MA0461.2 | chr2:225775293-225775303 | AACATATGTT | + | 6.02 | | Atoh1 | MA0461.2 | chr2:225775293-225775303 | AACATATGTT | - | 6.02 | | JUN | MA0488.1 | chr2:225774655-225774668 | AATATGATGTCAT | + | 6.41 | | ZBTB18 | MA0698.1 | chr2:225775177-225775190 | TGTCCAGATGTTG | + | 6.05 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_09679 | chr2:225773393-225776784 | CD14 | | SE_11129 | chr2:225773422-225776848 | CD20 | | SE_18264 | chr2:225773607-225775793 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19524 | chr2:225774075-225775559 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20427 | chr2:225774064-225775819 | CD56 | | SE_45675 | chr2:225773185-225776863 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 225774741 | 225775150 | | chr2 | 225774579 | 225775611 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I224908 | chr2 | 225773581 | 225776316 |
|
Enhancer Sequence | CTCATCCAGT CAGGCTAGTG AGCATGTGGT ATAAAGGAAC TTATCAAAGG ATCAGAGACA 60
ATAAAATGTG TAAGAACATG GAATATTATG TCAAAGATAG CAAAGCCTTA ATTCTGGCTC 120
TGTGTGAACT TGGGCGAGTT CATTATTCAC TCAGAGCCTG TTTTCTAGGC TGCAAAATGA 180
GGTAGTAATA CCTATTTCAC AGAGTTCTCA AAAGTTTTCA CATACACACA ATGTATAAGC 240
AACTGTGTAC TCAACTAGAG CTTGATGTTA ACATGCAGTG TTTTAATGGA TGTGAAATAA 300
GCCTATGCTT TTGTGTGGGG AATGTTTAAT TTTACATTTA AGAGATAGGG AGGAGAATTA 360
ATAACAGATA AAACAGAAAA GGAAGAAGCT GTTCATTTTA GTGAACTTCC ATTAAAATAT 420
GATGTCATTG AAGATTAAAA AAAAGAAAAG AATGCCTAAT GCCTTTCATG AGAAGCTGAG 480
AATTGTCAAA GTAGAGAGCA GTGAGAGAAA ACTCAAATTT TTTACTGAGC TGGATGTGTT 540
GAAACTAGAT TCTTGCCAAT CTGTTGCCTA GCAACCATGG TATTTGCCCT TGCCACCCCA 600
CAGTGAGCCG CAGGGCAATG TAGCACAGGG TGGACCAATA ACGTTGCTTA ATACACTTGT 660
GGTAGGTCAA GCAAGTGTTT CTACAAAGCT CTACAAACGT CAATGAATTC ATTTCAGTGC 720
TAGCATAATC TAGTTTCAAA AATCCAGCCA ATGTTCCTGA AAGTGTGGCC CACTGACTGT 780
ATGCATCAGA GTCACCTGAG CAGAAACCAC AGTGGGGCTG TGAGGGTGAA GACTCAGAGA 840
AGTTTTCTTT CCAGAGGAAC ATAGCAATTT TATAGCAAAA CACCCTATTG GCAGTTAGCA 900
TCGCAGTTAG GAGCCCAGGG ACGGAGCTGG TGGCATGTGT CCAGATGTTG GATCTGTCTA 960
TTCCTGGTTG TCTAATGCTG GCTGGGCAAG TTTCTTAATA TTTCTATGAC ATAGTTTCCT 1020
TGTTATTAAA AGGTGATAAT GATGATAATA ACAAACATAT GTTTGTAATT GCTACAAGTA 1080
AAGGGCTTAG AAGTGTATCT GGCACAAAGT AAGCAGTCAA TAAAGGTTAG CTGCTATTAG 1140
CAATTGGGGT CAAGACTTTT TGCAGTGTAA TTCTCTGGGA CCATTTCCCA GTCTTAGCTC 1200
AGCTCTTTGG TGACCTCTTT CTTCTTATCT GCTGTCTCCA GGCCTGACTA TTCATGTTCC 1260
ATTATCATCA CGGGATATTT GTAAGCAGGG CTTATCTTCT TCCCATCCTA TGAAGCACAG 1320
GTTTCACTTT ATCTTTATCC TTAAAATCAA GGACTACTAT GGGAGTTTTT GCAGGGTTTT 1380
CAGTACTAGT GACACAGAAA AATTAGCAGG GAATAAGGTA 1420
|
